Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Chemotherapy changes cytotoxic activity of NK-cells in cancer patients M. Stakheyeva, N. Yunusova, M. Patysheva [et al.]

Contributor(s): Yunusova, N | Patysheva, Marina R | Mitrofanova, Irina V | Faltin, V | Tuzikov, Sergey A | Slonimskaya, Elena M | Stakheyeva, Marina NMaterial type: ArticleArticleSubject(s): химиотерапия | цитотоксическая активность | онкологические больныеGenre/Form: статьи в журналах Online resources: Click here to access online In: AIP Conference Proceedings Vol. 1882. P. 020072-1-020072-4Abstract: In recent years, it has been shown that under certain conditions cytostatic agents (chemotherapy and radiotherapy) can restore the functioning of the immune system impaired by malignancy burden. The modifications of biological properties by cytostatics acting make cancer cells visible for the immune system recognition and elimination. Eighteen patients diagnosed with primary local breast (8) and gastric (10) cancer between 2014 and 2016 were enrolled in the investigation. The phenotypic features of NK were assessed by flow cytometry using mAb (BD Pharmingen) against CD45 (common leukocyte antigen) and CD56 (NK-marker) for surface staining, CD107a (LAMP-1), Perforin (PF) and Gransime B (GB) for intracellular staining. We examined NK populations in the peripheral blood of cancer patients before treatment and in 5 days after second course of NACT. We found that NK populations produced PF in cancer patents, which were absent before treatment, increased after NACT. Their emergence can be associated with the immunoactivating effects of chemotherapy, realized by the modification of tumor cells or elimination of immunosuppressive cells.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Библиогр.: 17 назв.

In recent years, it has been shown that under certain conditions cytostatic agents (chemotherapy and radiotherapy) can restore the functioning of the immune system impaired by malignancy burden. The modifications of biological properties by cytostatics acting make cancer cells visible for the immune system recognition and elimination. Eighteen patients diagnosed with primary local breast (8) and gastric (10) cancer between 2014 and 2016 were enrolled in the investigation. The phenotypic features of NK were assessed by flow cytometry using mAb (BD Pharmingen) against CD45 (common leukocyte antigen) and CD56 (NK-marker) for surface staining, CD107a (LAMP-1), Perforin (PF) and Gransime B (GB) for intracellular staining. We examined NK populations in the peripheral blood of cancer patients before treatment and in 5 days after second course of NACT. We found that NK populations produced PF in cancer patents, which were absent before treatment, increased after NACT. Their emergence can be associated with the immunoactivating effects of chemotherapy, realized by the modification of tumor cells or elimination of immunosuppressive cells.

There are no comments on this title.

to post a comment.
Share